跳至主要内容
临床试验/NCT06067295
NCT06067295招募中不适用

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

University of Southern California3 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年2月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
3
主要终点
Collection of biological specimens and clinical data for future research related to prostate cancer.

研究概览

简要总结

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

详细描述

PRIMARY OBJECTIVE:

I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer.

OUTLINE: This is an observational study.

Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Men of all racial and ethnic groups 18 years of age or older
  • Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
  • Prior participation on clinical trials is allowed

排除标准

  • Inability to give informed consent
  • Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer

研究组 & 干预措施

Observational

Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

干预措施: Non-Interventional Study (Other)

结局指标

主要结局

Collection of biological specimens and clinical data for future research related to prostate cancer.

时间窗: Up to 5 years

The objective of this study is to create a biorepository of biospecimen and clinical data. There is no primary clinical outcome for this study.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验